Ruxandra Draghia-Akli, EVP of Novavax NVAX, has filed 13 transactions, none an open-market purchase or sale. The latest trade was on 03/03.

Ruxandra Draghia-Akli

EVP, Research & Development

Company: Novavax NVAX
First filing: 24/11/13

Trades: 13 trades
Buys / sales: 0 / 0
12-month net buying: No record
Last trade: 03/03

Trading activity

Transactions

No filed transactions.